UCLH-6630 - LECANEMAB HOMECARE SERVICE

Published date: 5 March 2025

Contract summary

Industry

Pharmacy services - 85149000

Location of contract

NW1 2PB

Value of contract

£81,600 to £816,000

Procurement reference

CF-2881000D0O000000rwimUAA

Published date

5 March 2025

Closing date

26 March 2025

Closing time

12pm

Contract start date

3 November 2025

Contract end date

2 November 2027

Contract type

Service contract

Procedure type

Open procedure (above threshold)

Contract is suitable for SMEs?

No

Contract is suitable for VCSEs?

No

---

Description

The service requirements for the direct supply and administration of Lecanemab (Leqembi) in a patient's home, via a homecare delivery service. Lecanemab is indicated for the treatment of mild cognitive impairment and mild dementia due to Alzheimer's disease in adult patients that are apolipoprotein E ε 4 (ApoE ε 4) heterozygotes or non-carriers. The service is being offered by UCLH private Healthcare and will be for private patients only. The requirement is for a private homecare provider situated in the UK to provide this service.

---

More information

Additional text

To express interest and participate in the tender, please register and apply via Atamis e-sourcing portal https://health-family.force.com/s/Welcome.

Should Tenderers have any queries, or having problems using the portal, they should contact Helpdesk at:

Phone: 0800 9956035

E-mail: support-health@atamis.co.uk

---

How to apply

Follow the instructions given in the description or the more information section.

---

About the buyer

Contact name

Aaron Monaghan

Address

179a Tottenham Court Road
London
NW1 2PB
GB

Email

a.monaghan3@nhs.net

---

Share this notice

Is there anything wrong with this page?